Synairgen (SNG) Share Price

Health Care Sector


NOTE: This is based on 29 open tips for Synairgen (SNG)


Synairgen (SNG)
Latest Quote Price

5.74p

Synairgen (SNG)
Price Change (%)

0.00%


Latest Bid : 5.50p Latest Ask : 6.08p
High Today : 6.05p Low Today : 5.60p
This Years High : 9.80p This Years Low : 4.88p
Volume : 278,844 MKT Cap : £11.54M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only


Synairgen (SNG) Overview

In the 1970s, Synairgen founder, British immunophysician Professor Sir Stephen Holgate, began investigating how respiratory viruses can cause serious illness, with the aim of translating these insights into effective clinical treatments. Joined by fellow University of Southampton professors Donna Davies and Ratko Djukanovic in the 1990s, together the three formed Synairgen in 2003 with the sole aim of bringing these advances to patients.

Synairgen (SNG) Latest Tips

Type Tipster SectorScore Start date Performance
Hold Deutsche Bank Premium Only 2024-05-07 06:48:00 07/05/2024 -7.42%
Hold Richard Evans Premium Only 2021-11-10 07:45:00 10/11/2021 -96.78%
Speculative Buy Rupert Hargreaves Premium Only 2021-10-20 11:20:00 20/10/2021 -96.54%
Speculative Buy Rupert Hargreaves Premium Only 2021-06-16 14:25:00 16/06/2021 -96.55%
Watch Richard Evans Premium Only 2021-06-02 08:25:00 02/06/2021

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Synairgen (SNG) Active Short Positions

Fund Manager Position Date
No active short positions

See more short positions...


Latest Bid : 5.50p Latest Ask : 6.08p
High Today : 6.05p Low Today : 5.60p
This Years High : 9.80p This Years Low : 4.88p
Volume : 278,844 MKT Cap : £11.54M

Synairgen Overview

In the 1970s, Synairgen founder, British immunophysician Professor Sir Stephen Holgate, began investigating how respiratory viruses can cause serious illness, with the aim of translating these insights into effective clinical treatments. Joined by fellow University of Southampton professors Donna Davies and Ratko Djukanovic in the 1990s, together the three formed Synairgen in 2003 with the sole aim of bringing these advances to patients.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest Synairgen Tips

Type Tipster SectorScore Start date Performance
Hold Deutsche Bank Premium Only 2024-05-07 06:48:00 07/05/2024 -7.42%
Hold Richard Evans Premium Only 2021-11-10 07:45:00 10/11/2021 -96.78%
Speculative Buy Rupert Hargreaves Premium Only 2021-10-20 11:20:00 20/10/2021 -96.54%
Speculative Buy Rupert Hargreaves Premium Only 2021-06-16 14:25:00 16/06/2021 -96.55%
Watch Richard Evans Premium Only 2021-06-02 08:25:00 02/06/2021